secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001493152-25-027639
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director resigns citing governance concerns; Bioxytran hires independent expert for controls review
--------------------------------------------------------------------------------

- Anders Utter resigns from Bioxytran's Board and Audit Committee chair, effective Dec 7, 2025, citing need for enhanced oversight and controls.
- Utter's recommendations included strengthening segregation of duties, improving financial approval documentation, and legal review of a recent stock issuance.
- Company engages an independent third-party financial expert to review oversight, internal controls, and approval processes.
- No disagreement related to financial statements, accounting practices, or SEC disclosures, per filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000149315225027639/0001493152-25-027639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000149315225027639/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer